Millipore Sigma Vibrant Logo

662005 U0126 - CAS 109511-58-2 - Calbiochem

U0126, CAS 109511-58-2, is a potent and specific inhibitor of MEK1 (IC₅₀ = 72 nM) and MEK2 (IC₅₀ = 58 nM). The inhibition is noncompetitive with respect to both ATP and ERK.

U0126 - CAS 109511-58-2 - Calbiochem: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: 1,4-Diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene, MEK Inhibitor VI

Primary Target: MEK1 and MEK2
View Products on Sigmaaldrich.com
662005
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
109511-58-2C₁₈H₁₆N₆S₂•½C₂H₅OH

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
662005-10MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 10 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      662005-1MG
      Comprobando disponibilidad...
      —
      Disponibilidad a confirmar Disponibilidad a confirmar
      Ingrese cantidad 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          		 Frasco de vidrio 1 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Maximum Quantity is
          Al finalizar el pedido Más información
          Ahorró ()
           
          —
          Solicitar precio
          		 —
          662005-20MG
          Comprobando disponibilidad...
          —
          Disponibilidad a confirmar Disponibilidad a confirmar
          Ingrese cantidad 
          Suspendido
          Cantidades limitadas disponibles
          Debe confirmarse disponibilidad
            El resto: se avisará
              El resto: se avisará
              Se avisará
              Póngase en contacto con el Servicio de Atención al Cliente
              Contact Customer Service

              		 Ampolla de plást. 20 mg
              Recuperando precio...
              No pudo obtenerse el precio
              La cantidad mínima tiene que ser múltiplo de
              Maximum Quantity is
              Al finalizar el pedido Más información
              Ahorró ()
               
              —
              Solicitar precio
              		 —
              662005-5MG
              Comprobando disponibilidad...
              —
              Disponibilidad a confirmar Disponibilidad a confirmar
              Ingrese cantidad 
              Suspendido
              Cantidades limitadas disponibles
              Debe confirmarse disponibilidad
                El resto: se avisará
                  El resto: se avisará
                  Se avisará
                  Póngase en contacto con el Servicio de Atención al Cliente
                  Contact Customer Service

                  		 Frasco de vidrio 5 mg
                  Recuperando precio...
                  No pudo obtenerse el precio
                  La cantidad mínima tiene que ser múltiplo de
                  Maximum Quantity is
                  Al finalizar el pedido Más información
                  Ahorró ()
                   
                  —
                  Solicitar precio
                  		 —
                  Description
                  OverviewA potent and specific inhibitor of MEK1 (IC50 = 72 nM) and MEK2 (IC50 = 58 nM). The inhibition is noncompetitive with respect to both ATP and ERK. Has very little effect on other kinases such as Abl, Cdk2, Cdk4, ERK, JNK, MEKK, MKK-3, MKK-4/SEK, MKK-6, PKC, and Raf. Shown to block doxazosin-induced osteoblastic differentiation. Also acts as an immunosuppressant by effectively blocking IL-2 synthesis and T cell proliferation without affecting the long-term outcomes of either T cell activation or tolerance. Noncompetitive with respect to ATP. Also available in InSolution™ format (Cat. No. 662009).
                  Catalogue Number662005
                  Brand Family Calbiochem®
                  Synonyms1,4-Diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene, MEK Inhibitor VI
                  References
                  ReferencesChoi, Y.J., et al. 2011. Biochem. Biophys. Res. Commun. 416, 232.
                  DeSilva, D.R., et al. 1998. J. Immunol. 160, 4175.
                  Duncia, J.V., et al. 1998. Biorg. Med. Chem. Lett. 8, 2839.
                  Favata, M.F., et al. 1998. J. Biol. Chem. 273, 18623.
                  Product Information
                  CAS number109511-58-2
                  ATP CompetitiveN
                  FormWhite solid
                  Hill FormulaC₁₈H₁₆N₆S₂•½C₂H₅OH
                  Chemical formulaC₁₈H₁₆N₆S₂•½C₂H₅OH
                  ReversibleN
                  Structure formula ImageStructure formula Image
                  Quality LevelMQ100
                  Applications
                  Biological Information
                  Primary TargetMEK1 and MEK2
                  Primary Target IC<sub>50</sub>72 nM, 58 nm, against MEK1, and MEK2, respectively
                  Purity≥98% by HPLC
                  Physicochemical Information
                  Cell permeableN
                  Dimensions
                  Materials Information
                  Toxicological Information
                  Safety Information according to GHS
                  Safety Information
                  Product Usage Statements
                  Storage and Shipping Information
                  Ship Code Ambient Temperature Only
                  Toxicity Standard Handling
                  Storage -20°C
                  Protect from Light Protect from light
                  Do not freeze Ok to freeze
                  Special InstructionsUnstable in solution; reconstitute just prior to use.
                  Packaging Information
                  Packaged under inert gas Packaged under inert gas
                  Transport Information
                  Supplemental Information
                  Specifications
                  Global Trade Item Number
                  Número de referencia GTIN
                  662005-10MG 04055977261691
                  662005-1MG 07790788052249
                  662005-20MG 04055977261004
                  662005-5MG 04055977261011

                  Documentation

                  U0126 - CAS 109511-58-2 - Calbiochem Ficha datos de seguridad (MSDS)

                  Título

                  Ficha técnica de seguridad del material (MSDS) 

                  U0126 - CAS 109511-58-2 - Calbiochem Certificados de análisis

                  CargoNúmero de lote
                  662005

                  Referencias bibliográficas

                  Visión general referencias
                  Choi, Y.J., et al. 2011. Biochem. Biophys. Res. Commun. 416, 232.
                  DeSilva, D.R., et al. 1998. J. Immunol. 160, 4175.
                  Duncia, J.V., et al. 1998. Biorg. Med. Chem. Lett. 8, 2839.
                  Favata, M.F., et al. 1998. J. Biol. Chem. 273, 18623.

                  Folleto

                  Cargo
                  An Introduction to Inhibitors and Their Biological Applications - 1st Edition

                  Ficha técnica

                  Cargo
                  Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

                  Citas

                  Título
                • Choi, Y.J., et al. 2011. Biochem. Biophys. Res. Commun. 416, 232.
                • Oliveira, J.B., et al. 2007. Procedings of the National Academy of Science 104, 8953.
                • Chengyu Wu and Jiaoti Huang. 2007. Journal of Biological Chemistry 282, 3571.
                • Alexandra Thiel, Mira Heinonen, Johanna Rintahaka, Tuija Hallikainen, and Annabrita Hemmes, Dan A. Dixon, Caj Haglund, and Ari Ristimaki. (2006) EXPRESSION OF CYCLOOXYGENASE-2 IS REGULATED BY GSK-3 IN GASTRIC CANCER CELLS. Journal of Biological Chemistry in press,.
                • Thiel, A., et al. 2006. Journal of Biological Chemistry 281, 4564.
                • Basak, C., et al. 2005. Journal of Immunology 174, 5672.
                • Soonkyu Chung, et al. (2005) Conjugated linoleic acid promotes human adipocyte insulin resistance through NF-κB-dependent cytokine production. Journal of Biological Chemistry 280, 38445-38456.
                • Marie-Claire Delfini, et al. (2005) Control of the segmentation process by graded MAPK/ERK activation in the chick embryo. Proceedings of the National Academy of Science USA 102, 11343-11348.
                • Gutzmer, R., et al. 2005. Journal of Immunology 5224.
                • Monick, M.M., et al. 2005. Journal of Biological Chemistry 280, 2147.
                • Tang, Q-Q., et al. 2005. Proceedings of the National Academy of Sciences (USA) 102, 9766.
                • Junji Tsurutani, et al. (2005) Inhibition of the phosphatidylinositol 3-kinase/Akt/Mammalian target of rapamycin pathway but no the MEK/ERK Pathway attentuates laminin-meidated small cell lunch cancer cellular survival and resistance to Imatinib mesylate or chemolyte.. Cancer Research 65, 8423-8432.
                • Wojciechowski, W., et al. 2005. Journal of Immunology 174, 7859.
                • Wu, M-H., et al. 2005. The Journal of Clinical Endocrinology & Metabolism 90, 286.
                • Yung-Luen Yu, et al. (2005) MAP kinase-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival. Journal of Biological Chemistry 280, 29533-29542.
                • Naoto Inukai, et al. (2004) A novel hydrogen peroxide-induced phosphorylation and ubiquitination pathway leading to RNA polymerase II proteolysis. Journal of Biological Chemistry 279, 8190-8195.
                • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
                • Michael J. Cross, et al. (2002) The Shb Adaptor Protein Binds to Tyrosine 766 in the FGFR-1 and Regulates the Ras/MEK/MAPK Pathway via FRS2 Phosphorylation in Endothelial Cells. Molecular Biology of the Cell 13, 2881-2893.
                  		•
                  Ficha técnica

                  Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

                  Revision28-February-2012 RFH
                  Synonyms1,4-Diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene, MEK Inhibitor VI
                  DescriptionA potent and specific inhibitor of MEK1 (IC50 = 72 nM) and MEK2 (IC50 = 58 nM). The inhibition is noncompetitive with respect to MEK substrates, ATP and ERK. Has very little effect on other kinases, such as Abl, Cdk2, Cdk4, ERK, JNK, MEKK, MKK-3, MKK-4/SEK, MKK-6, PKC, and Raf. Shown to block doxazosin-induced osteoblastic differentiation. U0126 also acts as an immunosuppressant by effectively blocking IL-2 synthesis and T cell proliferation without affecting the long-term outcomes of either T cell activation or tolerance. Noncompetitive with respect to ATP. Also available in InSolution™ format (Cat. No. 662009.
                  FormWhite solid
                  Intert gas (Yes/No) Packaged under inert gas
                  CAS number109511-58-2
                  Chemical formulaC₁₈H₁₆N₆S₂•½C₂H₅OH
                  Structure formulaStructure formula
                  Purity≥98% by HPLC
                  SolubilityDMSO (200 mg/ml)
                  Storage Protect from light
                  -20°C
                  Do Not Freeze Ok to freeze
                  Special InstructionsUnstable in solution; reconstitute just prior to use.
                  Toxicity Standard Handling
                  ReferencesChoi, Y.J., et al. 2011. Biochem. Biophys. Res. Commun. 416, 232.
                  DeSilva, D.R., et al. 1998. J. Immunol. 160, 4175.
                  Duncia, J.V., et al. 1998. Biorg. Med. Chem. Lett. 8, 2839.
                  Favata, M.F., et al. 1998. J. Biol. Chem. 273, 18623.
                  Citation
                • Choi, Y.J., et al. 2011. Biochem. Biophys. Res. Commun. 416, 232.
                • Oliveira, J.B., et al. 2007. Procedings of the National Academy of Science 104, 8953.
                • Chengyu Wu and Jiaoti Huang. 2007. Journal of Biological Chemistry 282, 3571.
                • Alexandra Thiel, Mira Heinonen, Johanna Rintahaka, Tuija Hallikainen, and Annabrita Hemmes, Dan A. Dixon, Caj Haglund, and Ari Ristimaki. (2006) EXPRESSION OF CYCLOOXYGENASE-2 IS REGULATED BY GSK-3 IN GASTRIC CANCER CELLS. Journal of Biological Chemistry in press,.
                • Thiel, A., et al. 2006. Journal of Biological Chemistry 281, 4564.
                • Basak, C., et al. 2005. Journal of Immunology 174, 5672.
                • Soonkyu Chung, et al. (2005) Conjugated linoleic acid promotes human adipocyte insulin resistance through NF-κB-dependent cytokine production. Journal of Biological Chemistry 280, 38445-38456.
                • Marie-Claire Delfini, et al. (2005) Control of the segmentation process by graded MAPK/ERK activation in the chick embryo. Proceedings of the National Academy of Science USA 102, 11343-11348.
                • Gutzmer, R., et al. 2005. Journal of Immunology 5224.
                • Monick, M.M., et al. 2005. Journal of Biological Chemistry 280, 2147.
                • Tang, Q-Q., et al. 2005. Proceedings of the National Academy of Sciences (USA) 102, 9766.
                • Junji Tsurutani, et al. (2005) Inhibition of the phosphatidylinositol 3-kinase/Akt/Mammalian target of rapamycin pathway but no the MEK/ERK Pathway attentuates laminin-meidated small cell lunch cancer cellular survival and resistance to Imatinib mesylate or chemolyte.. Cancer Research 65, 8423-8432.
                • Wojciechowski, W., et al. 2005. Journal of Immunology 174, 7859.
                • Wu, M-H., et al. 2005. The Journal of Clinical Endocrinology & Metabolism 90, 286.
                • Yung-Luen Yu, et al. (2005) MAP kinase-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival. Journal of Biological Chemistry 280, 29533-29542.
                • Naoto Inukai, et al. (2004) A novel hydrogen peroxide-induced phosphorylation and ubiquitination pathway leading to RNA polymerase II proteolysis. Journal of Biological Chemistry 279, 8190-8195.
                • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
                • Michael J. Cross, et al. (2002) The Shb Adaptor Protein Binds to Tyrosine 766 in the FGFR-1 and Regulates the Ras/MEK/MAPK Pathway via FRS2 Phosphorylation in Endothelial Cells. Molecular Biology of the Cell 13, 2881-2893.
                  		•